The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial. - Berg M; Lorenzen EL; Jensen I; Thomsen MS; Lutz CM; Refsgaard L; Nissen HD; Offersen BV (Acta oncologica (Stockholm, Sweden), 2018)